Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 European Medicines Agency policies for clinical trials leave women unprotected.

Literature DB >> 17053276

European Medicines Agency policies for clinical trials leave women unprotected.

Maria Teresa Ruiz Cantero, Maria Angeles Pardo.

Abstract

Entities: Species

Mesh：

Year: 2006 PMID： 17053276 PMCID： PMC2465475 DOI： 10.1136/jech.2006.048769

Source DB: PubMed Journal: J Epidemiol Community Health ISSN： 0143-005X Impact factor: 3.710

× No keyword cloud information.

12 in total

1. Manufacturing uncertainty: adverse effects of drug development for women.

Authors: Patricia Peppin
Journal: Int J Law Psychiatry Date: 2003 Sep-Oct

2. Failing the public health--rofecoxib, Merck, and the FDA.

Authors: Eric J Topol
Journal: N Engl J Med Date: 2004-10-06 Impact factor: 91.245

3. Europe also needs agency for postmarketing surveillance.

Authors: Silvio Garattini
Journal: BMJ Date: 2005-03-05

Review 4. Women in early-phase clinical drug trials: have things changed over the past 20 years?

Authors: Jeanette Fleisch; Markus C Fleisch; Petra A Thürmann
Journal: Clin Pharmacol Ther Date: 2005-11 Impact factor: 6.875

5. Participation of women in clinical trials of drug therapies: a context for the controversies.

Authors: M N Prout; S S Fish
Journal: Medscape Womens Health Date: 2001-10

6. Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction.

Authors: P A Rochon; J P Clark; M A Binns; V Patel; J H Gurwitz
Journal: CMAJ Date: 1998-08-25 Impact factor: 8.262

Review 7. Do women have more adverse drug reactions?

Authors: M Rademaker
Journal: Am J Clin Dermatol Date: 2001 Impact factor: 7.403

Review 8. [Clinical trials with rofecoxib: analysis of the information from the gender perspective].

Authors: Susana Cascales Pérez; M Teresa Ruiz Cantero; María Angeles Pardo
Journal: Med Clin (Barc) Date: 2003-02-22 Impact factor: 1.725

Review 9. Gender differences in the prescribing of antipsychotic drugs.

Authors: Mary V Seeman
Journal: Am J Psychiatry Date: 2004-08 Impact factor: 18.112

Review 10. Sex differences in pharmacokinetics and pharmacodynamics.

Authors: Monica Gandhi; Francesca Aweeka; Ruth M Greenblatt; Terrence F Blaschke
Journal: Annu Rev Pharmacol Toxicol Date: 2004 Impact factor: 13.820

8 in total

1. Sex differences in cardiovascular drug-induced adverse reactions causing hospital admissions.

Authors: Eline M Rodenburg; Bruno H Stricker; Loes E Visser
Journal: Br J Clin Pharmacol Date: 2012-12 Impact factor: 4.335

2. Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands.

Authors: Eline M Rodenburg; Bruno H Ch Stricker; Loes E Visser
Journal: Br J Clin Pharmacol Date: 2011-01 Impact factor: 4.335

3. A framework to analyse gender bias in epidemiological research.

Authors: María Teresa Ruiz-Cantero; Carmen Vives-Cases; Lucía Artazcoz; Ana Delgado; Maria Mar García Calvente; Consuelo Miqueo; Isabel Montero; Rocío Ortiz; Elena Ronda; Isabel Ruiz; Carme Valls
Journal: J Epidemiol Community Health Date: 2007-12 Impact factor: 3.710